Tsuruha Holdings stock (JP3536150000): Japanese drugstore chain posts latest earnings and outlines growth focus

Tsuruha Holdings has reported its recent financial results and updated investors on store expansion and profitability measures, offering fresh insights into the Japanese drugstore operator’s outlook for domestic and overseas markets.

Tsuruha Holdings recently released financial results that give investors fresh insight into the performance of the Japanese drugstore chain and its plans for continued expansion. The company reported figures for the fiscal year ended May 31, 2024, and has since provided updates on its medium-term strategy, including store openings and profitability initiatives, according to information on its investor relations site and recent disclosures from the group’s management as of 07/10/2024 and 01/09/2025.Tsuruha Holdings IR as of 07/10/2024 and Tsuruha Holdings IR as of 01/09/2025

As of: 16.05.2026

By the editorial team – specialized in equity coverage.

At a glance

• Name: Tsuruha Holdings Inc
• Sector/industry: Drugstores, pharmacy retail
• Headquarters/country: Sapporo, Japan
• Core markets: Japanese domestic drugstore and pharmacy market
• Key revenue drivers: Prescription drugs, over-the-counter medicines, daily necessities, cosmetics
• Home exchange/listing venue: Tokyo Stock Exchange (ticker: 3391)
• Trading currency: Japanese yen (JPY)

Tsuruha Holdings: core business model

Tsuruha Holdings operates one of Japan’s largest drugstore chains, focusing on a combination of prescription dispensing, over-the-counter medicines, health foods, cosmetics, and daily consumer goods. The group functions as a listed holding company, encompassing several regional chains that operate under different banners but follow a broadly similar format in terms of merchandise mix, store layout, and customer focus.Tsuruha Holdings company outline as of 03/15/2025

The company’s business model relies on high store density in key regions, long opening hours, and an emphasis on convenience-oriented locations, often near residential neighborhoods and transport hubs. Stores generally combine pharmacy services with general merchandising, targeting everyday household purchases and health-related needs in a single visit, which is a common approach among Japanese drugstore chains.

In addition to physical stores, Tsuruha Holdings has been building out its digital capabilities, including e-commerce channels and mobile apps for loyalty members. While online sales still represent a modest proportion of total revenue, digital tools support customer retention via personalized promotions, point programs, and information on health products, according to recent investor materials that highlight digitalization as a medium-term priority.Tsuruha Holdings presentation materials as of 10/04/2024

Main revenue and product drivers for Tsuruha Holdings

Tsuruha Holdings generates revenue from several product categories, with prescription drugs and over-the-counter medicines forming an important base. Prescription dispensing volumes are influenced by demographics and healthcare utilization in Japan, a country with a rapidly aging population. Over-the-counter medicines, health foods, and supplements provide additional health-related revenue, often supported by in-store pharmacists and registered sellers who provide guidance.

Another major revenue contributor is the sale of daily necessities such as toiletries, cleaning supplies, and packaged food. These items drive traffic and repeat visits, especially from local residents who use Tsuruha drugstores as neighborhood convenience outlets for everyday purchases. Cosmetics and beauty products are also a meaningful segment, benefiting from demand among younger and middle-aged consumers for skincare, makeup, and personal care items.

Gross margin is affected by the product mix between higher-margin categories like cosmetics and private-brand goods and lower-margin, high-turnover items such as certain drugs and daily necessities. Tsuruha Holdings has been expanding private-label products and exclusive offerings to support profitability. The company’s presentations emphasize merchandising optimization and category management as key levers for margin improvement, alongside cost control measures at the store and headquarters level.Tsuruha Holdings presentation materials as of 10/04/2024

Recent earnings trends and store expansion

For the fiscal year ended May 31, 2024, Tsuruha Holdings reported consolidated net sales and profit figures that reflected continued expansion in store count and steady consumer demand in Japan’s drugstore sector. While the exact revenue and profit amounts are detailed in the company’s results release, management highlighted growth in sales compared with the prior fiscal year and pointed to progress in integrating acquired chains and optimizing the store network, according to the earnings materials published in July 2024.Tsuruha Holdings IR as of 07/10/2024

During the same reporting period, Tsuruha Holdings continued to open new stores, particularly in suburban and regional areas, and closed or consolidated some locations to improve efficiency. The balance between new openings and closures is intended to maintain overall growth while addressing overlaps in the network. Management has indicated in its presentations that the group is focusing on improving existing store productivity through better merchandising, labor management, and use of data analytics.

Looking ahead, the company’s medium-term plans include a target for cumulative store openings and a focus on regions where its market share is still relatively low. At the same time, Tsuruha Holdings has pointed to rising costs such as labor and utilities, as well as changes in consumer behavior, as factors that require ongoing cost discipline and pricing strategies. The guidance discussed in its investor materials emphasizes a balance between expansion, profitability, and returns to shareholders via stable dividends, according to the most recent strategy update.Tsuruha Holdings IR as of 01/09/2025

Why Tsuruha Holdings matters for US investors

For US investors, Tsuruha Holdings offers exposure to Japan’s consumer and healthcare retail market, an economy characterized by high urbanization and an aging population. The company’s core business is sensitive to domestic consumption trends, prescription volumes, and healthcare policy in Japan, factors that may behave differently from US retail dynamics. This can contribute to diversification benefits in a global equity portfolio.

Although the primary listing is on the Tokyo Stock Exchange in Japanese yen, some US investors may gain access through international brokerage platforms that support trading in Japanese equities or through funds that hold Japanese retail and healthcare-related stocks. Currency movements between the US dollar and the yen can affect returns for US-based shareholders, making exchange-rate development an additional factor to monitor.

From a sector perspective, Tsuruha Holdings operates in a space that combines elements of healthcare, consumer staples, and discretionary spending. The company’s performance can be influenced by trends such as self-medication, demand for preventive healthcare products, and competition from supermarkets, convenience stores, and e-commerce platforms, all of which are relevant themes for global consumer and healthcare investors.

Conclusion

Tsuruha Holdings stands out as a major player in Japan’s drugstore and pharmacy market, combining prescription services with everyday consumer goods. Recent financial results for the year ended May 31, 2024, and subsequent strategy updates underline the group’s focus on store expansion, profitability improvements, and stable shareholder returns. For US investors, the stock offers indirect exposure to Japanese consumer and healthcare trends, though factors such as domestic competition, cost pressures, and currency movements remain important variables to monitor alongside the company’s execution of its medium-term plan.

Disclaimer: This article does not constitute investment advice. Stocks are volatile financial instruments.